Precigen, Inc. (PGEN) earnings
PGEN earnings moved a median of 0.00% by the close. Quarterly and annual PGEN reports and results, each read against the price at its own news timestamp. Back to the PGEN overview →
23 measured PGEN earnings events.
Where these PGEN earnings landedvs 23 measured PGEN earnings reactions
| Middle 50% of PGEN earnings reactions | -3.69% to +2.64% |
|---|---|
| Median reaction (to close) | 0.00% |
| Measured reactions | 23 |
Point-in-time · zero look-ahead
Half of the 23 PGEN earnings events with a measured close landed between -3.69% and +2.64%; 48% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q PRECIGEN, INC. For: Jun 30 | SEC filing · Form 10-Q | -3.53% | -2.68% | |
| Precigen Reports Second Quarter 2026 Financial Results Highlighted by Accelerating PAPZIMEOS Revenue Growth | Press release | -3.53% | -2.68% | |
| Precigen to Announce Second Quarter 2026 Financial Results and Provide Business Updates on August 4 | Press release | +0.78% | +7.23% | |
| Form 10-Q PRECIGEN, INC. For: Mar 31 | SEC filing · Form 10-Q | -3.49% | +0.44% | |
| Precigen Reports First Quarter 2026 Financial Results and Business Updates | Press release | -3.49% | +0.44% | |
| Precigen to Announce First Quarter 2026 Financial Results and Provide Business Updates on May 13 | Press release | +0.00% | +0.96% | |
| Form 10-K PRECIGEN, INC. For: Dec 31 | SEC filing · Form 10-K | +2.20% | -4.66% | |
| Precigen to Announce Third Quarter 2025 Financial Results and Provide Business Updates on November 13 | Press release | -0.51% | +0.00% | |
| Form 10-Q PRECIGEN, INC. For: Jun 30 | SEC filing · Form 10-Q | +0.52% | +4.37% | |
| Form 10-Q PRECIGEN, INC. For: Mar 31 | SEC filing · Form 10-Q | +3.54% | +3.15% | |
| Precigen Reports First Quarter 2025 Financial Results and Business Updates | Press release | +3.54% | +3.15% | |
| Form 10-K/A PRECIGEN, INC. For: Dec 31 | SEC filing · Form 10-K | -0.65% | +0.00% | |
| Form 10-K PRECIGEN, INC. For: Dec 31 | SEC filing · Form 10-K | -0.56% | +1.12% | |
| Form 10-Q PRECIGEN, INC. For: Sep 30 | SEC filing · Form 10-Q | -4.35% | -10.86% | |
| Precigen Reports Third Quarter 2024 Financial Results and Business Updates | Press release | -4.35% | -10.86% | |
| Form 10-Q PRECIGEN, INC. For: Jun 30 | SEC filing · Form 10-Q | +3.64% | -2.73% | |
| Form 10-Q PRECIGEN, INC. For: Mar 31 | SEC filing · Form 10-Q | +4.35% | +4.35% | |
| Precigen Reports First Quarter 2024 Financial Results and Business Updates | Press release | +4.35% | +4.35% | |
| Precigen to Announce First Quarter 2024 Financial Results on May 14th and Host a Conference Call on June 3rd following the Late-breaking Oral Presentation for PRGN-2012 at the 2024 ASCO Annual Meeting | Press release | +0.00% | -1.53% | |
| Form 10-K/A PRECIGEN, INC. For: Dec 31 | SEC filing · Form 10-K | +0.00% | -5.04% | |
| Form 10-K PRECIGEN, INC. For: Dec 31 | SEC filing · Form 10-K | -3.19% | +2.13% | |
| Form 10-Q PRECIGEN, INC. For: Sep 30 | SEC filing · Form 10-Q | -8.16% | -10.66% | |
| Precigen Reports Third Quarter 2023 Financial Results and Progress of Clinical Programs | Press release | -8.16% | -10.66% |
Keep exploring
More PGEN: analyst actions → · SEC filings → · PGEN overview →